Pro-Dex, Inc.
NASDAQ:PDEXMedical - Instruments & Supplies
+$3.54 today
- Market cap
- $204.61M
- Beta
- -0.00
- P/E (TTM)
- 17.1
- EPS (TTM)
- $3.75
Volume 0.04M
Average 0.04M
PDEX Total Current Assets
All assets expected to be converted to cash or used up within one year.
Pro-Dex, Inc.NASDAQ: PDEX
Total Current Assets · Q3 FY2026 · quarter ended Mar 2026
Total current assets rises 7.5% from a year ago
Total current assets stood at $53.71M at the end of Q3 FY2026, up 7.5% from a year earlier and up 9.2% from the prior quarter. Over 3 fiscal years it compounded at +14.9% a year.
Context
- Total current assets amounted to 71.6% of total assets at the end of Q3 FY2026, down 6.1 pp from a year earlier.
- Total current assets increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current assets keeps rising in the next quarterly balance sheet after a +7.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 47.3M USD
- Year-over-year change
- +29.2%
- 4-year CAGR
- +11.0%
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 47.3M | +29.2% |
| FY2024 | 2024-06-30 | 36.61M | +18.2% |
| FY2023 | 2023-06-30 | 30.98M | -0.6% |
| FY2022 | 2022-06-30 | 31.17M | +0.0% |
| FY2021 | 2021-06-30 | 31.17M | — |
Total Current Assets vs competitors
How PDEX compares with its peers on the latest reported figures
- PDEX's Mar 2026 total current assets of $53.71M is the 3rd highest of the 9 companies compared; the peer median is $42.52M.
- Its year-over-year change of +7.5% is the 6th highest of 9, against a peer median of +21.5%.
- Total current assets amounts to 71.6% of total assets for PDEX, versus a peer median of 89.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $76.53M | +149.6% | +108.4% | 98.0% | |
| Mar 2026 | $54.8M | +5.7% | +10.8% | 86.9% | |
| Mar 2026 | $53.71M | +7.5% | +14.9% | 71.6% | |
| Mar 2026 | $49.73M | +5.2% | -23.2% | 53.2% | |
| Mar 2026 | $49.23M | -28.8% | -23.9% | 78.9% | |
| Mar 2026 | $35.81M | +56.6% | +0.2% | 99.1% | |
| Mar 2026 | $31.36M | +13.9% | +15.4% | 92.0% | |
| Mar 2026 | $18.38M | +29.0% | +36.4% | 10.2% | |
| Mar 2026 | $10.51M | +282.0% | — | 100.0% | |
| Peer median (excluding PDEX) | $42.52M | +21.5% | +10.8% | 89.5% | |
Competitors are the stored peer set for PDEX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 849K | 849K | 2.94M | 2.63M | 419K |
| Short-term Investments | 755K | 755K | 1.13M | 4.22M | 6.74M |
| Net Receivables | 15.38M | 15.38M | 9.95M | 13.89M | 17.49M |
| Inventory | 12.68M | 12.68M | 16.17M | 15.27M | 22.21M |
| Other Current Assets | 710K | 710K | 494K | 262K | 24K |
| Total Current Assets | 31.17M | 31.17M | 30.98M | 36.61M | 47.3M |
| Property, Plant & Equipment (Net) | 13.42M | 13.42M | 13.2M | 12.65M | 1.05M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 118K | 118K | 81K | 54K | 26K |
| Long-term Investments | 4.08M | 4.08M | 7.52M | 1.56M | 148K |
| Tax Assets | 256K | 256K | 0 | 1.56M | 1.42M |
| Other Non-current Assets | 42K | 42K | 42K | 42K | 11.26M |
| Total Non-current Assets | 17.92M | 17.92M | 20.84M | 15.87M | 13.9M |
| Total Assets | 49.09M | 49.09M | 51.82M | 52.48M | 61.19M |
| Account Payables | 3.76M | 3.76M | 2.26M | 4.51M | 4.61M |
| Short-term Debt | 3.29M | 3.29M | 3.83M | 4.37M | 6.15M |
| Tax Payables | 544K | 544K | 453K | 632K | 186K |
| Deferred Revenue | 1.01M | 1.01M | 0 | 14K | 202K |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 1.63M |
| Total Current Liabilities | 11.35M | 11.35M | 9.68M | 12.89M | 14.63M |
| Long-term Debt | 10.25M | 10.25M | 8.91M | 7.54M | 9.25M |
| Deferred Tax Liabilities | 0 | 0 | 8K | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 12.3M | 12.3M | 10.56M | 8.72M | 9.93M |
| Total Liabilities | 23.66M | 23.66M | 20.23M | 21.61M | 24.56M |
| Common Stock | 7.68M | 7.68M | 6.77M | 3.92M | 704K |
| Retained Earnings | 17.75M | 17.75M | 24.82M | 26.95M | 35.93M |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 25.43M | 25.43M | 31.59M | 30.87M | 36.63M |
| Total Debt | 15.97M | 15.97M | 14.79M | 13.55M | 16.58M |
| Net Debt | 15.12M | 15.12M | 11.86M | 10.92M | 16.16M |
Pro-Dex, Inc.
NASDAQ:PDEX
Intrinsic Alpha fair value
Locked
Current Price
$63.94
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.